STAGE I HYPOPHARYNGEAL CARCINOMA AJCC V8
Clinical trials for STAGE I HYPOPHARYNGEAL CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE I HYPOPHARYNGEAL CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE I HYPOPHARYNGEAL CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to shield cancer patients from painful mouth sores
Symptom relief Recruiting nowThis study is testing if adding an investigational drug called BMX-001 to standard symptom care can better prevent severe mouth sores in people receiving combined chemotherapy and radiation for head and neck cancer. About 98 participants will be randomly assigned to receive eithe…
Matched conditions: STAGE I HYPOPHARYNGEAL CARCINOMA AJCC V8
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Mar 16, 2026 15:26 UTC
-
Scientists probe why cancer patients skip crucial throat exercises
Knowledge-focused Recruiting nowThis study aims to understand why some head and neck cancer patients follow, and others skip, prescribed swallowing exercises after radiation therapy. Researchers will collect blood samples and ask patients to fill out questionnaires to see if factors like mood, pain, immune syst…
Matched conditions: STAGE I HYPOPHARYNGEAL CARCINOMA AJCC V8
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC